Brief: Anika Therapeutics Q4 Revenue USD 42.971 Million
13/03/2024 20:06
Mar 13 (Reuters) - Anika Therapeutics Q4 net income USD -63 million. * Q4 pretax profit USD -63.204 million * Q4 income from operations USD -63.781 million * Q4 gross profit USD 26.329 million
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%